270 related articles for article (PubMed ID: 25001061)
41. Serum miR-1297: a promising diagnostic biomarker in esophageal squamous cell carcinoma.
Wang C; Li Q; Liu F; Chen X; Nesa EU; Guan S; Liu B; Han L; Tan B; Wang D; Chen P; Liu X; Zhang H; Sun Y; Cheng Y
Biomarkers; 2016 Sep; 21(6):517-22. PubMed ID: 27152453
[TBL] [Abstract][Full Text] [Related]
42. Serum microRNA-15a level acts as a potential diagnostic and prognostic biomarker for human esophageal squamous cell carcinoma.
Li J; Li M; Gao F; Ge X
Cancer Biomark; 2017; 18(1):11-17. PubMed ID: 27802201
[TBL] [Abstract][Full Text] [Related]
43. Cytokeratin 19 fragment antigen 21-1 as an independent predictor for definitive chemoradiotherapy sensitivity in esophageal squamous cell carcinoma.
Yan HJ; Wang RB; Zhu KL; Jiang SM; Zhao W; Xu XQ; Feng R
Chin Med J (Engl); 2012 Apr; 125(8):1410-5. PubMed ID: 22613644
[TBL] [Abstract][Full Text] [Related]
44. YKL-40 expression in human hepatocellular carcinoma: a potential biomarker?
Xiao XQ; Hassanein T; Li QF; Liu W; Zheng YH; Chen J
Hepatobiliary Pancreat Dis Int; 2011 Dec; 10(6):605-10. PubMed ID: 22146624
[TBL] [Abstract][Full Text] [Related]
45. Determining the concentrations of the squamous cell carcinoma antigen using the Maglumi 2000 automatic analyzer.
Ni X; Qi S
Minerva Med; 2014 Feb; 105(1):57-61. PubMed ID: 24184959
[TBL] [Abstract][Full Text] [Related]
46. Serum vascular endothelial growth factor receptor-3 levels in patients with esophageal squamous cell cancer.
Su Mer A; Demir A; Kemik AS; Yavuz A; Suvak B; Du Lger AC; Purisa S; Kemik O
Ann Ital Chir; 2017; 88():20-25. PubMed ID: 28447586
[TBL] [Abstract][Full Text] [Related]
47. Clinical significance of joint detection of serum CEA, SCCA, and bFGF in the diagnosis of lung cancer.
Zhao W; Yu H; Han Z; Gao N; Xue J; Wang Y
Int J Clin Exp Pathol; 2015; 8(8):9506-11. PubMed ID: 26464712
[TBL] [Abstract][Full Text] [Related]
48. Diagnostic value of serum squamous cell carcinoma antigen and cytokeratin fragment antigen 21-1 for sinonasal inverted papilloma: an exploratory study.
Zhang Z; Xu B; Wang L; Yan X; Li S; Jiang Y; Yu L
Rhinology; 2024 Jun; 62(3):353-361. PubMed ID: 38189590
[TBL] [Abstract][Full Text] [Related]
49. [Diagnostic application of detecting AgNOR in peripheral blood T lymphocyte in patients with esophageal carcinoma].
Wang JY; Rong TH; Liang YR; Long H; Chen QL; Ma GW
Ai Zheng; 2004 May; 23(5):577-80. PubMed ID: 15142458
[TBL] [Abstract][Full Text] [Related]
50. Serum YKL-40 in risk assessment for colorectal cancer: a prospective study of 4,496 subjects at risk of colorectal cancer.
Johansen JS; Christensen IJ; Jørgensen LN; Olsen J; Rahr HB; Nielsen KT; Laurberg S; Brünner N; Nielsen HJ
Cancer Epidemiol Biomarkers Prev; 2015 Mar; 24(3):621-6. PubMed ID: 25597749
[TBL] [Abstract][Full Text] [Related]
51. A novel serum microRNA signature to screen esophageal squamous cell carcinoma.
Huang Z; Zhang L; Zhu D; Shan X; Zhou X; Qi LW; Wu L; Zhu J; Cheng W; Zhang H; Chen Y; Zhu W; Wang T; Liu P
Cancer Med; 2017 Jan; 6(1):109-119. PubMed ID: 28035762
[TBL] [Abstract][Full Text] [Related]
52. [Serum levels of miRNA-183 in patients with esophageal squamous cell carcinoma and its diagnostic value].
Chen J; Chen M
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2018 Oct; 43(10):1048-1053. PubMed ID: 30523223
[TBL] [Abstract][Full Text] [Related]
53. Combination assay for tumor markers in oral squamous cell carcinoma.
Kurokawa H; Yamashita Y; Tokudome S; Kajiyama M
J Oral Maxillofac Surg; 1997 Sep; 55(9):964-6. PubMed ID: 9294507
[TBL] [Abstract][Full Text] [Related]
54. Predictive Value of Serum miR-10b, miR-29c, and miR-205 as Promising Biomarkers in Esophageal Squamous Cell Carcinoma Screening.
Xu H; Yao Y; Meng F; Qian X; Jiang X; Li X; Gao Z; Gao L
Medicine (Baltimore); 2015 Nov; 94(44):e1558. PubMed ID: 26554762
[TBL] [Abstract][Full Text] [Related]
55. [Clinical Significance of Tumor Marker Detection in Patients
with Advanced Squamous Cell Carcimoma of the Lung].
Liang P; Li J
Zhongguo Fei Ai Za Zhi; 2016 Oct; 19(10):641-647. PubMed ID: 27760591
[TBL] [Abstract][Full Text] [Related]
56. Preoperative serum immunoglobulin G and A antibodies to Porphyromonas gingivalis are potential serum biomarkers for the diagnosis and prognosis of esophageal squamous cell carcinoma.
Gao SG; Yang JQ; Ma ZK; Yuan X; Zhao C; Wang GC; Wei H; Feng XS; Qi YJ
BMC Cancer; 2018 Jan; 18(1):17. PubMed ID: 29298684
[TBL] [Abstract][Full Text] [Related]
57. Evaluation of serum squamous cell carcinoma antigen as a novel biomarker for diagnosis of hepatocellular carcinoma in Egyptian patients.
Hussein MM; Ibrahim AA; Abdella HM; Montasser IF; Hassan MI
Indian J Cancer; 2008; 45(4):167-72. PubMed ID: 19112206
[TBL] [Abstract][Full Text] [Related]
58. Serum YKL-40 as a marker for cervical adenocarcinoma.
Mitsuhashi A; Matsui H; Usui H; Nagai Y; Tate S; Unno Y; Hirashiki K; Seki K; Shozu M
Ann Oncol; 2009 Jan; 20(1):71-7. PubMed ID: 18723551
[TBL] [Abstract][Full Text] [Related]
59. Preoperative squamous cell carcinoma antigen and albumin serum levels predict the survival of patients with stage T1-3N0M0 esophageal squamous cell carcinoma: a retrospective observational study.
Wu LL; Liu X; Huang W; Lin P; Long H; Zhang LJ; Ma GW
J Cardiothorac Surg; 2020 May; 15(1):115. PubMed ID: 32456707
[TBL] [Abstract][Full Text] [Related]
60. Tumor-associated autoantibodies against Fascin as a novel diagnostic biomarker for esophageal squamous cell carcinoma.
Chen WX; Hong XB; Hong CQ; Liu M; Li L; Huang LS; Xu LY; Xu YW; Peng YH; Li EM
Clin Res Hepatol Gastroenterol; 2017 Jun; 41(3):327-332. PubMed ID: 27956255
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
